Clinical Trials Browser

Phase 2 × Not yet recruiting × Esophageal Neoplasms × Clear all

NCT07530549 2026-04-15

A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07376876 2026-01-29

Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Anastomotic Leak

NCT07330583 2026-01-09

Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07324018 2026-01-08

Spirulina Derivative for Radiation Esophagitis

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07283991 2025-12-16

BRICES

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07233850 2025-11-18

A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Colorectal Neoplasms

NCT07222657 2025-10-31

Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07019181 2025-06-13

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06965829 2025-05-11

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06933966 2025-04-18

ATTENUATION

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT06914687 2025-04-06

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT06692270 2025-02-28

Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06814158 2025-02-07

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT06643689 2024-11-14

TAPES

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms, Esophageal Stenosis

NCT06681285 2024-11-08

CAR-RMEC

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT05628610 2024-08-13

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06469060 2024-07-01

TRACE

Phase 2 Not yet recruiting

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT06464614 2024-06-18

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT04889742 2023-12-26

HETERERO

Phase 2 Not yet recruiting

EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

NCT06152978 2023-12-01

A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05996484 2023-08-21

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms